相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cancer statistics, 2022
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2022)
Loss of Long Noncoding RNA NXTAR in Prostate Cancer Augments Androgen Receptor Expression and Enzalutamide Resistance
Ruchi Ghildiyal et al.
CANCER RESEARCH (2022)
Targeting KDM4A-AS1 represses AR/AR-Vs deubiquitination and enhances enzalutamide response in CRPC
Boya Zhang et al.
ONCOGENE (2022)
Cistrome and transcriptome analysis identifies unique androgen receptor (AR) and AR-V7 splice variant chromatin binding and transcriptional activities
Paul Basil et al.
SCIENTIFIC REPORTS (2022)
Androgen receptor variant-7 regulation by tenascin-c induced src activation
Rintu Thomas et al.
CELL COMMUNICATION AND SIGNALING (2022)
Advances on the role of the deleted in breast cancer (DBC1) in cancer and autoimmune diseases
Fang Qiannan et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2021)
KIF15-Mediated Stabilization of AR and AR-V7 Contributes to Enzalutamide Resistance in Prostate Cancer
Lin Gao et al.
CANCER RESEARCH (2021)
Androgen receptor splice variant 7 functions independently of the full length receptor in prostate cancer cells
Jiaqian Liang et al.
CANCER LETTERS (2021)
LNCcation: lncRNA localization and function
Mary Catherine Bridges et al.
JOURNAL OF CELL BIOLOGY (2021)
Effects of MTX-23, a Novel PROTAC of Androgen Receptor Splice Variant-7 and Androgen Receptor, on CRPC Resistant to Second-Line Antiandrogen Therapy
Geun Taek Lee et al.
MOLECULAR CANCER THERAPEUTICS (2021)
Tissue Expression of Androgen Receptor Splice Variant 7 at Radical Prostatectomy Predicts Risk of Progression in Untreated Nonmetastatic Prostate Cancer
Alessandro Sciarra et al.
ONCOLOGY (2021)
Identification of AR-V7 downstream genes commonly targeted by AR/AR-V7 and specifically targeted by AR-V7 in castration resistant prostate cancer
Masahiro Sugiura et al.
TRANSLATIONAL ONCOLOGY (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Mechanisms and markers of resistance to androgen signaling inhibitors in patients with metastatic castration-resistant prostate cancer
Anita Csizmarik et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2021)
The long noncoding RNA H19 regulates tumor plasticity in neuroendocrine prostate cancer
Neha Singh et al.
NATURE COMMUNICATIONS (2021)
Huaier Extract Inhibits Prostate Cancer Growth via Targeting AR/AR-V7 Pathway
Zhengfang Liu et al.
FRONTIERS IN ONCOLOGY (2021)
Treatment and trials in non-metastatic castration-resistant prostate cancer
Soum D. Lokeshwar et al.
NATURE REVIEWS UROLOGY (2021)
Resistance to second-generation androgen receptor antagonists in prostate cancer
Keith T. Schmidt et al.
NATURE REVIEWS UROLOGY (2021)
ARVib suppresses growth of advanced prostate cancer via inhibition of androgen receptor signaling
Chengfei Liu et al.
ONCOGENE (2021)
Long noncoding RNA GAS5 interacts and suppresses androgen receptor activity in prostate cancer cells
Shidong Lv et al.
PROSTATE (2021)
Selective degradation of AR-V7 to overcome castration resistance of prostate cancer
Yuan Liu et al.
CELL DEATH & DISEASE (2021)
LncRNA PCBP1-AS1-mediated AR/AR-V7 deubiquitination enhances prostate cancer enzalutamide resistance
Boya Zhang et al.
CELL DEATH & DISEASE (2021)
A Systematic Review and Meta-Analysis of Randomized Controlled Trials With Novel Hormonal Therapies for Non-Metastatic Castration-Resistant Prostate Cancer: An Update From Mature Overall Survival Data
Martina Maggi et al.
FRONTIERS IN ONCOLOGY (2021)
Improved Androgen Receptor Splice Variant 7 Detection Using a Highly Sensitive Assay to Predict Resistance to Abiraterone or Enzalutamide in Metastatic Prostate Cancer Patients
Denis Maillet et al.
EUROPEAN UROLOGY ONCOLOGY (2021)
LncRNA-mediated posttranslational modifications and reprogramming of energy metabolism in cancer
Yue-Tao Tan et al.
CANCER COMMUNICATIONS (2021)
Bruceantin targets HSP90 to overcome resistance to hormone therapy in castration-resistant prostate cancer
Sue Jin Moon et al.
THERANOSTICS (2021)
Recruitment of miR-8080 by luteolin inhibits androgen receptor splice variant 7 expression in castration-resistant prostate cancer
Aya Naiki-Ito et al.
CARCINOGENESIS (2020)
Biomarkers of response to advanced prostate cancer therapy
Roberto Iacovelli et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2020)
Anti-inflammatory effects of nobiletin on TLR4/TRIF/IRF3 and TLR9/IRF7 signaling pathways in prostate cancer cells
Asuman Deveci Ozkan et al.
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY (2020)
The E3 ubiquitin ligase STUB1 attenuates cell senescence by promoting the ubiquitination and degradation of the core circadian regulator BMAL1
Kifayat Ullah et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2020)
A novel androgen receptor antagonist JJ-450 inhibits enzalutamide-resistant mutant ARF876L nuclear import and function
Zeyu Wu et al.
PROSTATE (2020)
p300-Mediated Acetylation of Histone Demethylase JMJD1A Prevents Its Degradation by Ubiquitin Ligase STUB1 and Enhances Its Activity in Prostate Cancer
Songhui Xu et al.
CANCER RESEARCH (2020)
The splicing modulator sulfonamide indisulam reduces AR-V7 in prostate cancer cells
James E. Melnyk et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2020)
Combination therapy with androgen receptor N-terminal domain antagonist EPI-7170 and enzalutamide yields synergistic activity in AR-V7-positive prostate cancer
Yukiyoshi Hirayama et al.
MOLECULAR ONCOLOGY (2020)
Five-year Survival Prediction and Safety Outcomes with Enzalutamide in Men with Chemotherapy-naive Metastatic Castration-resistant Prostate Cancer from the PREVAIL Trial
Andrew J. Armstrong et al.
EUROPEAN UROLOGY (2020)
Small Heat Shock Proteins in Cancers: Functions and Therapeutic Potential for Cancer Therapy
Jixian Xiong et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
The AKR1C3/AR-V7 complex maintains CRPC tumour growth by repressing B4GALT1 expression
Bin Wang et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)
Aberrant activation of super enhancer and choline metabolism drive antiandrogen therapy resistance in prostate cancer
Simeng Wen et al.
ONCOGENE (2020)
Role of androgen receptor splice variant-7 (AR-V7) in prostate cancer resistance to 2nd-generation androgen receptor signaling inhibitors
Yezi Zhu et al.
ONCOGENE (2020)
Preclinical studies using cisplatin/carboplatin to restore the Enzalutamide sensitivity via degrading the androgen receptor splicing variant 7 (ARv7) to further suppress Enzalutamide resistant prostate cancer
Fu-Ju Chou et al.
CELL DEATH & DISEASE (2020)
Targeting GRP78-dependent AR-V7 protein degradation overcomes castration-resistance in prostate cancer therapy
Yuning Liao et al.
THERANOSTICS (2020)
ARv7 Represses Tumor-Suppressor Genes in Castration-Resistant Prostate Cancer
Laura Cato et al.
CANCER CELL (2019)
Prospective Multicenter Validation of Androgen Receptor Splice Variant 7 and Hormone Therapy Resistance in High-Risk Castration-Resistant Prostate Cancer: The PROPHECY Study
Andrew J. Armstrong et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
LncRNA PCAT1 activates AKT and NF-κB signaling in castration-resistant prostate cancer by regulating the PHLPP/FKBP51/IKKα complex
Zhiqun Shang et al.
NUCLEIC ACIDS RESEARCH (2019)
Androgen receptor modulators: a review of recent patents and reports (2012-2018)
Shinya Fujii et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2019)
Hsp-27 and NF-κB pathway is associated with AR/AR-V7 expression in prostate cancer cells
Ilker Kiliccioglu et al.
GENE (2019)
Interplay Between SOX9, Wnt/-Catenin and Androgen Receptor Signaling in Castration-Resistant Prostate Cancer
Namrata Khurana et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
The long non-coding RNA Cerox1 is a post transcriptional regulator of mitochondrial complex I catalytic activity
Tamara M. Sirey et al.
ELIFE (2019)
Targeting Super-Enhancers as a Therapeutic Strategy for Cancer Treatment
Yi He et al.
FRONTIERS IN PHARMACOLOGY (2019)
Arginine vasopressin receptor 1a is a therapeutic target for castration-resistant prostate cancer
Ning Zhao et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
LncRNA-p21 alters the antiandrogen enzalutamide-induced prostate cancer neuroendocrine differentiation via modulating the EZH2/STAT3 signaling
Jie Luo et al.
NATURE COMMUNICATIONS (2019)
Long Noncoding RNA (lncRNA)-Mediated Competing Endogenous RNA Networks Provide Novel Potential Biomarkers and Therapeutic Targets for Colorectal Cancer
Liye Wang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Hsp70 and Hsp40 inhibit an inter-domain interaction necessary for transcriptional activity in the androgen receptor
Bahareh Eftekharzadeh et al.
NATURE COMMUNICATIONS (2019)
Androgen receptor splice variant-7 expression emerges with castration resistance in prostate cancer
Adam Sharp et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Biological Evolution of Castration-resistant Prostate Cancer
Alastair Davies et al.
EUROPEAN UROLOGY FOCUS (2019)
CK2 Pro-Survival Role in Prostate Cancer Is Mediated via Maintenance and Promotion of Androgen Receptor and NFκB p65 Expression
Janeen H. Trembley et al.
PHARMACEUTICALS (2019)
DBC1 promotes castration-resistant prostate cancer by positively regulating DNA binding and stability of AR-V7
Sue Jin Moon et al.
ONCOGENE (2018)
Inhibition of the Wnt/beta-Catenin Pathway Overcomes Resistance to Enzalutamide in Castration-Resistant Prostate Cancer
Zhuangzhuang Zhang et al.
CANCER RESEARCH (2018)
Targeting the Hsp40/Hsp70 Chaperone Axis as a Novel Strategy to Treat Castration-Resistant Prostate Cancer
Michael A. Moses et al.
CANCER RESEARCH (2018)
Novel Junction-specific and Quantifiable In Situ Detection of AR-V7 and its Clinical Correlates in Metastatic Castration-resistant Prostate Cancer
Yezi Zhu et al.
EUROPEAN UROLOGY (2018)
Super-Enhancer-Driven Long Non-Coding RNA LINC01503, Regulated by TP63, Is Over-Expressed and Oncogenic in Squamous Cell Carcinoma
Jian-Jun Xie et al.
GASTROENTEROLOGY (2018)
Therapeutic Potential of Leelamine, a Novel Inhibitor of Androgen Receptor and Castration-Resistant Prostate Cancer
Krishna B. Singh et al.
MOLECULAR CANCER THERAPEUTICS (2018)
Analysis of the androgen receptor-regulated lncRNA landscape identifies a role for ARLNC1 in prostate cancer progression
Yajia Zhang et al.
NATURE GENETICS (2018)
Diverse AR-V7 cistromes in castration-resistant prostate cancer are governed by HoxB13
Zhong Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Comparing sequencing of abiraterone and enzalutamide in men with metastatic castration-resistant prostate cancer: A retrospective study
Takeshi Azuma
PROSTATE (2018)
Coactivator condensation at super-enhancers links phase separation and gene control
Benjamin R. Sabari et al.
SCIENCE (2018)
nc886 is induced by TGF-beta and suppresses the microRNA pathway in ovarian cancer
Ji-Hye Ahn et al.
NATURE COMMUNICATIONS (2018)
Current status of androgen receptor-splice variant 7 inhibitor niclosamide in castrate-resistant prostate-cancer
Navid Sobhani et al.
INVESTIGATIONAL NEW DRUGS (2018)
Enzalutamide: A Review in Castration-Resistant Prostate Cancer
Lesley J. Scott
DRUGS (2018)
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer
Chengfei Liu et al.
NATURE COMMUNICATIONS (2018)
Down-regulation of AR splice variants through XPO1 suppression contributes to the inhibition of prostate cancer progression
Amro Aboukameel et al.
Oncotarget (2018)
Systematic and functional characterization of novel androgen receptor variants arising from alternative splicing in the ligand-binding domain
T. Uo et al.
ONCOGENE (2017)
Preclinical Study using Malat1 Small Interfering RNA or Androgen Receptor Splicing Variant 7 Degradation Enhancer ASC-J9® to Suppress Enzalutamide-resistant Prostate Cancer Progression
Ronghao Wang et al.
EUROPEAN UROLOGY (2017)
Comprehensive Profiling of the Androgen Receptor in Liquid Biopsies from Castration-resistant Prostate Cancer Reveals Novel Intra-AR Structural Variation and Splice Variant Expression Patterns
Bram De laere et al.
EUROPEAN UROLOGY (2017)
EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part II: Treatment of Relapsing, Metastatic, and Castration-Resistant Prostate Cancer
Philip Cornford et al.
EUROPEAN UROLOGY (2017)
Clinical Significance of Androgen Receptor Splice Variant-7 mRNA Detection in Circulating Tumor Cells of Men With Metastatic Castration- Resistant Prostate Cancer Treated With First- and Second-Line Abiraterone and Enzalutamide
Emmanuel S. Antonarakis et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Targeting AR Variant-Coactivator Interactions to Exploit Prostate Cancer Vulnerabilities
Fiorella Magani et al.
MOLECULAR CANCER RESEARCH (2017)
Niclosamide and Bicalutamide Combination Treatment Overcomes Enzalutamide- and Bicalutamide-Resistant Prostate Cancer
Chengfei Liu et al.
MOLECULAR CANCER THERAPEUTICS (2017)
Downregulation of androgen receptors by NaAsO2 via inhibition of AKT-NF-B and HSP90 in castration resistant prostate cancer
Yunlim Kim et al.
PROSTATE (2017)
CX4945 suppresses the growth of castration-resistant prostate cancer cells by reducing AR-V7 expression
Chuangzhong Deng et al.
WORLD JOURNAL OF UROLOGY (2017)
lncRNA requirements for mouse acute myeloid leukemia and normal differentiation
M Joaquina Delás et al.
eLife (2017)
Heat shock protein 70 inhibitors suppress androgen receptor expression in LNCaP95 prostate cancer cells
Kazuaki Kita et al.
CANCER SCIENCE (2017)
The RNA helicase DDX39B and its paralog DDX39A regulate androgen receptor splice variant AR-V7 generation
Daisuke Nakata et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
Second-Generation HSP90 Inhibitor Onalespib Blocks mRNA Splicing of Androgen Receptor Variant 7 in Prostate Cancer Cells
Roberta Ferraldeschi et al.
CANCER RESEARCH (2016)
Treatment of metastatic castration-resistant prostate cancer (mCRPC) with enzalutamide
Giulia Baciarello et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2016)
Emerging data on androgen receptor splice variants in prostate cancer
Subing Cao et al.
ENDOCRINE-RELATED CANCER (2016)
Kinesin-12 motors cooperate to suppress microtubule catastrophes and drive the formation of parallel microtubule bundles
Hauke Drechsler et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Targeting Hsp90/Hsp70-Based Protein Quality Control for Treatment of Adult Onset Neurodegenerative Diseases
William B. Pratt et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 55 (2015)
Androgen Receptor Splice Variants Dimerize to Transactivate Target Genes
Duo Xu et al.
CANCER RESEARCH (2015)
Intracrine Androgens and AKR1C3 Activation Confer Resistance to Enzalutamide in Prostate Cancer
Chengfei Liu et al.
CANCER RESEARCH (2015)
Generation 2.5 Antisense Oligonucleotides Targeting the Androgen Receptor and Its Splice Variants Suppress Enzalutamide-Resistant Prostate Cancer Cell Growth
Yoshiaki Yamamoto et al.
CLINICAL CANCER RESEARCH (2015)
Safety and effectiveness of enzalutamide in men with metastatic, castration-resistant prostate cancer
Julie N. Graff et al.
EXPERT OPINION ON PHARMACOTHERAPY (2015)
The Cistrome and Gene Signature of Androgen Receptor Splice Variants in Castration Resistant Prostate Cancer Cells
Ji Lu et al.
JOURNAL OF UROLOGY (2015)
NF-kappa B2/p52:c-Myc:hnRNPA1 Pathway Regulates Expression of Androgen Receptor Splice Variants and Enzalutamide Sensitivity in Prostate Cancer
Nagalakshmi Nadiminty et al.
MOLECULAR CANCER THERAPEUTICS (2015)
LncRNA Khps1 Regulates Expression of the Proto-oncogene SPHK1 via Triplex-Mediated Changes in Chromatin Structure
Anna Postepska-Igielska et al.
MOLECULAR CELL (2015)
NAR Breakthrough Article Targeting chromatin binding regulation of constitutively active AR variants to overcome prostate cancer resistance to endocrine-based therapies
Siu Chiu Chan et al.
NUCLEIC ACIDS RESEARCH (2015)
The RNA-binding protein Sam68 regulates expression and transcription function of the androgen receptor splice variant AR-V7
Jacqueline Stockley et al.
SCIENTIFIC REPORTS (2015)
LncRNA HOTAIR Enhances the Androgen-Receptor-Mediated Transcriptional Program and Drives Castration-Resistant Prostate Cancer
Ali Zhang et al.
CELL REPORTS (2015)
Targeting heat shock proteins in metastatic castration-resistant prostate cancer
Arun A. Azad et al.
NATURE REVIEWS UROLOGY (2015)
Inhibition of NF-kappa B signaling restores responsiveness of castrate-resistant prostate cancer cells to anti-androgen treatment by decreasing androgen receptor-variant expression
R. Jin et al.
ONCOGENE (2015)
Niclosamide Inhibits Androgen Receptor Variants Expression and Overcomes Enzalutamide Resistance in Castration-Resistant Prostate Cancer
Chengfei Liu et al.
CLINICAL CANCER RESEARCH (2014)
AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer
Emmanuel S. Antonarakis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Enzalutamide in Metastatic Prostate Cancer before Chemotherapy REPLY
Tomasz M. Beer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
REST mediates androgen receptor actions on gene repression and predicts early recurrence of prostate cancer
Charlotte Svensson et al.
NUCLEIC ACIDS RESEARCH (2014)
Mechanisms of the androgen receptor splicing in prostate cancer cells
L. L. Liu et al.
ONCOGENE (2014)
GATA2 facilitates steroid receptor coactivator recruitment to the androgen receptor complex
Bin He et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Nobiletin suppresses cell viability through AKT Pathways in PC-3 and DU-145 prostate cancer cells
Jianchu Chen et al.
BMC PHARMACOLOGY & TOXICOLOGY (2014)
Enzalutamide in Metastatic Prostate Cancer before Chemotherapy
T. M. Beer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
The Noncoding RNA MALAT1 Is a Critical Regulator of the Metastasis Phenotype of Lung Cancer Cells
Tony Gutschner et al.
CANCER RESEARCH (2013)
Cell cycle regulation by long non-coding RNAs
Masatoshi Kitagawa et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2013)
Long Noncoding RNA MALAT-1 is a New Potential Therapeutic Target for Castration Resistant Prostate Cancer
Shancheng Ren et al.
JOURNAL OF UROLOGY (2013)
Mini-review: Foldosome regulation of androgen receptor action in prostate cancer
Laia Querol Cano et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2013)
lncRNA-dependent mechanisms of androgen-receptor-regulated gene activation programs
Liuqing Yang et al.
NATURE (2013)
Androgen receptors in hormone-dependent and castration-resistant prostate cancer
Ayesha A. Shafi et al.
PHARMACOLOGY & THERAPEUTICS (2013)
TALEN-engineered AR gene rearrangements reveal endocrine uncoupling of androgen receptor in prostate cancer
Michael D. Nyquist et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
The activity of the androgen receptor variant AR-V7 is regulated by FOXO1 in a PTEN-PI3K-AKT-dependent way
Sanjay N. Mediwala et al.
PROSTATE (2013)
Androgen receptor splice variants are resistant to inhibitors of Hsp90 and FKBP52, which alter androgen receptor activity and expression
Ayesha A. Shafi et al.
STEROIDS (2013)
Sam68 modulates the promoter specificity of NF-κB and mediates expression of CD25 in activated T cells
Kai Fu et al.
NATURE COMMUNICATIONS (2013)
Constitutively-active androgen receptor variants function independently of the HSP90 chaperone but do not confer resistance to HSP90 inhibitors
Joanna L. Gillis et al.
ONCOTARGET (2013)
Distinct Transcriptional Programs Mediated by the Ligand-Dependent Full-Length Androgen Receptor and Its Splice Variants in Castration-Resistant Prostate Cancer
Rong Hu et al.
CANCER RESEARCH (2012)
The Androgen Receptor Gene Mutations Database: 2012 Update
Bruce Gottlieb et al.
HUMAN MUTATION (2012)
The mutational landscape of lethal castration-resistant prostate cancer
Catherine S. Grasso et al.
NATURE (2012)
Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
Howard I. Scher et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Effect of the heat shock protein HSP27 on androgen receptor expression and function in prostate cancer cells
Matthias B. Stope et al.
WORLD JOURNAL OF UROLOGY (2012)
ASC-J9 Suppresses Castration-Resistant Prostate Cancer Growth through Degradation of Full-length and Splice Variant Androgen Receptors
Shinichi Yamashita et al.
NEOPLASIA (2012)
Alternatively spliced androgen receptor variants
Scott M. Dehm et al.
ENDOCRINE-RELATED CANCER (2011)
Diagnostic performance of the PCA3 urine test
George Leighton Lee et al.
NATURE REVIEWS UROLOGY (2011)
Abiraterone and Increased Survival in Metastatic Prostate Cancer
Johann S. De Bono et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
The Bioreductive Prodrug PR-104A Is Activated under Aerobic Conditions by Human Aldo-Keto Reductase 1C3
Christopher P. Guise et al.
CANCER RESEARCH (2010)
The Nuclear-Retained Noncoding RNA MALAT1 Regulates Alternative Splicing by Modulating SR Splicing Factor Phosphorylation
Vidisha Tripathi et al.
MOLECULAR CELL (2010)
Constitutively active androgen receptor splice variants expressed in castration-resistant prostate cancer require full-length androgen receptor
Philip A. Watson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer
Chris Tran et al.
SCIENCE (2009)
Splicing of a novel androgen receptor exon generates a constitutively active androgen receptor that mediates prostate cancer therapy resistance
Scott M. Dehm et al.
CANCER RESEARCH (2008)
Cooperative interactions between androgen receptor (AR) and heat-shock protein 27 facilitate AR transcriptional activity
Arnina Zoubeidi et al.
CANCER RESEARCH (2007)
Evidence for calpain-mediated androgen receptor cleavage as a mechanism for androgen independence
Stephen J. Libertini et al.
CANCER RESEARCH (2007)
Constitutive activation of the androgen receptor by a point mutation in the hinge region: A new mechanism for androgen-independent growth in prostate cancer
J Ceraline et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
DD3PCA3-based molecular urine analysis for the diagnosis of prostate cancer
D Hessels et al.
EUROPEAN UROLOGY (2003)
Regulation of signaling protein function and trafficking by the hsp90/hsp70-based chaperone machinery
WB Pratt et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2003)
Molecular biology of the androgen receptor
EP Gelmann
JOURNAL OF CLINICAL ONCOLOGY (2002)
分享论文
